Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

TECHNICIAN-BCPA: Beyond Triptans- Exploring Novel Therapeutic Agents for Acute Migraine Treatment


Date: Sep 22, 2021 07:00 PM - 07:45 PM

Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212

CE Hours

1.00

CE Units

0.100

Registration closes on Nov 05, 2021 11:55 PM

Activity Type

  • Application

Target Audience(s)

  • Technicians

Accreditation(s)

 
 
 
 
 
Accreditation Council for Pharmacy Education
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 
 
 
 

Joint Provider(s)

Bexar County Pharmacy Association (BCPA) and Central Texas Society of Health-System Pharmacists (CTSHP)

Requirements for CE Credit

  • The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted. 
  • The entire session must be attended to receive credit. No partial credit will be given. 
  • Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation. 
  • To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth. 
  • All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant. 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Nov 05, 2021 at 11:55 PM

Registration Closed  

Upon completion of this activity, participants will be able to:
                        1. List pharmacologic options available for acute migraine treatment
                        2. Recognize the limitations of medications available for acute migraine treatment
                        3. Describe patients that may benefit from the use of novel therapeutic options for acute migraines
 
 

Speaker(s)/Author(s)

Rebekah Benitez

Activity Number

0445-9999-21-013-L01-T
Date: 09/22/21
Time: 07:00 PM - 07:45 PM

CE Hours

1.00

Location

https://uiw.zoom.us/j/98056297305
Registration Closed